Long-term effects of Graves' ophthalmopathy on health-related quality of life

European Journal of Endocrinology

Volumn 146, Issue 6, 2002, Pages 751-757

  Terwee, Caroline ^a   Wakelkamp, Iris ^a   Tan, Stevie ^a   Dekker, Friedo ^a   Prummel, Mark F ^a   Wiersinga, Wilmar ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OPHTHALMOLOGY; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOMATOLOGY; VALIDATION PROCESS; VISUAL ACUITY;

EID: 0036299579     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460751     Document Type: Article

References (16)

1. Graves' ophthalmopathy: Current concepts regarding the pathogenesis and management
2. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: Measurement by the Medical Outcome Study instrument
3. Development of a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy: The GO-QOL
4. Long-term follow-up of Graves' ophthalmopathy in an incidence cohort
5. The MOS3.6-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection
6. EuroQol - A new facility for the measurement of health-related quality of life
7. Flaws in mortality data. The hazard of ignoring comorbid disease
8. Clinical Activity Score as a guide in the management of patients with Graves' ophthalmopathy
9. The Sickness Impact Profile: Conceptual formulation and methodology for the development of a health status measure
10. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations
11. Interpretation and validity of changes in scores on the Graves' Ophthalmopathy Quality of Life questionnaire (GO-QOL) after different treatments
12. Generalizability of valuations on health states collected with the EuroQol questionnaire
13. Test-retest reliability of the GO-QOL: A disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy
14. Quality of life and associated characteristics in a large national sample of adults with diabetes
15. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism